Detalhe da pesquisa
1.
Disability Related to Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(4): 772-777, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31669175
2.
Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 25(9): 1869-1874, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085305
3.
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.
Biol Blood Marrow Transplant
; 25(12): 2468-2473, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394265
4.
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.
Biol Blood Marrow Transplant
; 24(2): 373-380, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051021
5.
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(4): 710-716, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26475726
6.
Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease.
Haematologica
; 99(10): 1618-23, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24997150
7.
Clinical benefit of response in chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 18(10): 1517-24, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22683612
8.
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 18(11): 1649-55, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22691695